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Abstract The suitability of the triaminopyridine derivative
flupirtine, an analgesic drug with antioxidative property [Gassen,
M., Pergande, G. and Youdim, M.B.H. (1998) Biochem.
Pharmacol. 56, 1323^1329], for the preservation of mitochon-
drial integrity from oxidative stress-induced damage was studied.
Rat liver mitochondria were exposed to strong oxidative stress as
generated by Fe2+ plus ascorbate. Peroxidation damage of
membrane lipids was followed by the measurement of thiobarbi-
turic acid reactive substances. Protein oxidation was estimated
by electron spin resonance spectroscopy, after labeling of the
‘peroxidized’ mitochondria with 4-maleimido-2,2,6,6-tetra-
methylpiperidine-1-oxyl. We found that (i) low concentrations
of flupirtine (10 WM) protect lipids and also proteins (with lesser
efficiency) from attacks of reactive oxygen species; (ii) flupirtine
remarkably delayed the decline of complex mitochondrial
functions, such as the respiratory control or the Ca2+ retention
capacity of mitochondria, under oxidative stress; and (iii) the
ADP/ATP antiporter (ANT), a main component of the oxidative
phosphorylation machinery as well as a core component of the
permeability transition pore complex, seems to be a membrane
protein particularly protected by flupirtine. In conclusion, the
preservation of the Ca2+ buffer capacity of mitochondria and of
the ANT activity against oxidative stress supports an anti-
apoptotic application of flupirtine. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
In the etiology of a wide variety of diseases (e.g. ischemia/
reperfusion injury) or in the aging process the participation of
reactive oxygen species (ROS) is now widely accepted [1,2].
Mitochondria are a major source of ROS production in the
cell and are organelles which are particularly susceptible to
oxidative stress (see [1,3,4] for recent reviews). Defective oxi-
dative phosphorylation, e.g. such as in ADP/ATP antiporter
(ANT)-de¢cient mice, elevates markedly the production of
ROS [5]. In addition, highly energized mitochondria are also
dangerous for the cell, since the reduced state of respiratory
chain electron carriers supports the formation of superoxide
by one-electron transfer reactions [3,6]. Consequently, ‘mild
uncoupling’ of mitochondria decreases their ability to gener-
ate ROS [3,7]. Moreover, oxidative stress seems to damage the
components of the oxidative phosphorylation machinery dif-
ferentially [8,9]. Thus, it was found with senescent £ies that
the ANT was the only inner mitochondrial membrane protein
exhibiting an age-associated increase in carbonyls [8]. Gener-
ally, oxidative stress decreases the activity of the components
of oxidative phosphorylation and promotes the permeability
transition (PT) of mitochondria, a process resulting in the loss
of functional integrity [10,11]. Therefore, the discovery of
compounds protecting mitochondria from radical attacks
might be of great importance in the prevention or therapy
of ROS-related diseases.
Flupirtine, a cationic triaminopyridine derivative (for chem-
ical structure, see Fig. 1) used as a non-opioid analgesic with
muscle relaxant properties [12], also acts protectively against
oxidative stress as demonstrated in experiments with cells or
‘functionally dead’ mitochondria [13^15]. This observation
stimulated us to characterize the potential ability of £upirtine
to preserve the functional integrity of mitochondria upon oxi-
dative stress. First, lipid peroxidation and protein oxidation
were analyzed in order to gain insight in the antioxidative
power of £upirtine on these membrane constituents. Second,
the oxidative damage of membrane constituents was corre-
lated with the decline of complex functional properties, such
as the respiratory control, Ca2 retention capacity or the ex-
change of adenine nucleotides across the inner mitochondrial
membrane by the ANT. We found that £upirtine is able to
protect signi¢cantly the functional integrity of mitochondria
exposed to strong, short-term oxidative stress as generated by
Fe2 plus ascorbate.
2. Materials and methods
2.1. Chemicals
Atractyloside, 5,5P-dimethyl-1-pyrroline-N-oxide (DMPO), 4-male-
imido-2,2,6,6-tetramethylpiperidine-1-oxyl (MAL-6), safranin O, K-to-
copherol, adenosine-5P-diphosphate (ADP), glutamate, malate, ethyl-
ene diamine tetraacetic acid (EDTA), ascorbate and FeSO4 were from
Sigma-Aldrich. Flupirtine ([2-amino-3-ethoxycarbonylamino-6-(4-£u-
oro-benzylamino)-pyridine maleate]) was a gracious gift from Asta
Medica (Frankfurt, Germany). [14C]ADP was purchased from Amer-
sham. Sucrose was from Carl Roth (Karlsruhe, Germany). All other
chemicals were of the highest analytical grade available.
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2.2. Isolation of rat liver mitochondria (RLM)
Female Wistar strain rats (150^250 g) were housed in air-condi-
tioned rooms (22‡C) under a 12-h light^dark cycle. Food (commer-
cially available pellets) and water were given ad libitum. Mitochondria
were prepared from liver essentially as in [10], but homogenization
was done in ice-cold sucrose^Tris bu¡er (250 mM sucrose, 1 mM
Tris^HCl bu¡er, pH 7.4) supplemented with 1 mM EDTA. Su-
crose^Tris bu¡er applied in all other steps of the isolation procedure
was EDTA-free. The protein content in the stock suspension was
estimated by a modi¢ed biuret method.
2.3. Peroxidation of mitochondria and measurement of lipid
peroxidation
Mitochondria (V4 mg protein/ml) suspended in ‘peroxidation me-
dium’ (100 mM KCl, 10 mM Tris, pH 7.4) were subjected, in the
absence and in the presence of antioxidants, to oxidative stress gen-
erated by 50 WM Fe2 plus 100 WM ascorbate at 25‡C [10]. Peroxi-
dation of mitochondrial lipids was assessed by measuring the thio-
barbituric acid reactive substances (TBARS) essentially as described
[16]. Brie£y, aliquots of the reaction mixture (100 Wl) were removed
after various incubation periods (15, 30, 45, 60, 75 and 120 min) and
transferred to 1 ml of a 1:1 (v/v) mixture of acetic acid (2 M) and
trichloroacetic acid (10% w/v in water). The denatured reaction mix-
ture was centrifuged after 30 min in a benchtop centrifuge. To 450 Wl
of the supernatant, 800 Wl of a thiobarbituric acid solution (0.37%
(w/v) in 3.7 mM NaOH) were added and the solution was boiled for
30 min. The resulting optical density was recorded at 532 nm in a
Perkin-Elmer Sigma 2 photometer.
2.4. Electron spin resonance (ESR) spectroscopy measurements
2.4.1. Antioxidative activity of £upirtine. The antioxidative capa-
bility of £upirtine was assessed indirectly by hydroxyl radical-DMPO
spin trapping in the presence of various concentrations of £upirtine.
Brie£y, H2O2 (1 Wl of a 30% solution in water) was rapidly added to
1 ml phosphate-bu¡ered saline (PBS) medium supplemented with
0.1 or 1 mM DMPO, 0.1 mM £upirtine and 50 WM Fe2. An aliquot
of the reaction mixture was immediately transferred to an ESR-quartz
£at cell, and the DMPO/OH spectrum recorded with a Bruker ECS
106 ESR spectrometer at 9.77 GHz. The instrumental operating pa-
rameters were: incident microwave power = 15.9 mW, modulation am-
plitude = 1 G, time constant = 1.28 ms, conversion time = 10.24 ms,
¢eld sweep = 100 G.
2.4.2. Protein oxidation. Mitochondria were treated with ‘peroxi-
dation medium’ in the absence and presence of various concentrations
of £upirtine as described above. Subsequently, in aliquots of the ‘per-
oxidation medium’, mitochondria were spun down, washed with ice-
cold sucrose^Tris bu¡er, resuspended in the same bu¡er and, ¢nally,
the mitochondria (5 mg protein) were labeled with the protein-speci¢c
spin label MAL-6 at 4‡C for about 18 h [17]. Afterwards, the reaction
mixture was centrifuged and repeatedly washed with suspension me-
dium to remove non-covalently bound spin label and, ¢nally, the
mitochondria were resuspended in 1 ml bu¡er. The instrumental op-
erating parameters were the same as above. The W/S ratio of immo-
bilized MAL-6 was estimated from the signal amplitudes (see inlet of
Fig. 2). The W/S ratio is considered to be the measure of the immo-
bilization of MAL-6 to ‘free’ (W) and ‘hidden’ (S, membrane-em-
bedded) protein sulfhydryl groups [18].
2.5. Respiration and ANT activity
The oxygen consumption of control and peroxidized mitochondria
in active and resting states (state 3 and state 4) was measured polaro-
graphically using a Clark-type electrode in a thermostated chamber
maintained at 25‡C. The ‘respiration medium’ was composed of 110
mM mannitol, 60 mM KCl, 60 mM Tris^HCl, 10 mM K2HPO4, 0.5
mM Na2EDTA and 5 mM glutamate plus 5 mM malate as respira-
tory substrates (pH 7.4).
ANT activity in the samples of control or peroxidized mitochondria
was measured at 0‡C using the inhibitor stop technique [19]. Brie£y,
the forward exchange reaction was initiated by rapid addition of 0.1
ml 0.4 mM [14C]ADP (speci¢c activity 4500 dpm/nmol) to an aliquot
of 0.3 ml mitochondrial suspension (V3 mg protein) and stopped
after a 10 s incubation period by the addition of 0.2 ml 1 mM atrac-
tyloside. Non-speci¢c binding of [14C]ADP to mitochondria was esti-
mated by the incubation of mitochondrial samples with 0.33 mM
atractyloside prior to the addition of [14C]ADP.
2.6. Ca2+ retention capacity
The Ca2 retention capacity of energized RLM was measured by
the incubation of mitochondria in EDTA-free ‘respiration medium’
(1 mg protein/ml) at 25‡C, pH 7.4. Ca2 was added as 25-nmol pulses
to the incubation mixture up to the collapse of the membrane poten-
tial, recorded £uorometrically with safranin as a membrane potential
probe [20].
2.7. Statistical and mathematical analysis
The statistical signi¢cance of the experimental data was determined
by one-way analysis of variance followed by Dunnett’s t-test. Di¡er-
ences are considered signi¢cant if P (two-sided)6 0.05 (SAS/STAT
6.12 software) [21].
3. Results
3.1. Peroxidation of lipids
RLM exposed to Fe2 plus ascorbate-induced oxidative
stress are peroxidized in a time-dependent manner as indi-
cated by the formation of TBARS from membrane lipids
(see Fig. 1). Even in the presence of low concentrations of
£upirtine, such as 5 WM, TBARS formation slows down sig-
ni¢cantly. Flupirtine (e¡ector concentration, EC50% = 10 þ 3
WM; seven experiments) protects membrane lipids e¡ectively
from Fe2/ascorbate-induced oxidative stress comparable to
the classical antioxidant K-tocopherol (EC50% = 20 þ 5 WM;
four experiments) does, whereas the highly water-soluble
spin trap DMPO exerts no protection at this low concentra-
tions (not shown). Since £upirtine was applied as a salt with
maleate as the anionic constituent, we checked also a possible
antioxidative e¡ect of maleate on the peroxidative process.
However, maleate was without any antioxidative activity,
even at millimolar concentrations (data not shown). Further-
more, we found that the protection of membrane lipids from
peroxidation by £upirtine is in line with its capability to di-
minish the e⁄cacy of the spin trapping of the hydroxyl radical
Fig. 1. E¡ect of £upirtine on the production of TBARS. RLM were
exposed for a total incubation period of 120 min to ascorbate (100
WM)/Fe2 (50 WM) in the presence of various concentrations of £u-
pirtine. The extent of lipid peroxidation was measured as accumula-
tion of TBARS as described in Section 2. Data are expressed as
mean þ S.D. for seven independent preparations.
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by the spin trap DMPO (see Fig. 2). Thus, the concentration
of the DMPO/OH adduct obtained when DMPO was mixed
with Fe2 plus H2O2 (Fig. 2A), was clearly reduced in the
presence of £upirtine (Fig. 2B,C) indicating that £upirtine
competes the spin-trapping of hydroxyl radicals by DMPO.
3.2. Protein oxidation
The oxidative damage of membrane proteins was estimated
by measuring the W/S ratio, which decreased in membranes
exposed to oxidative stress [22,23]. For the estimation, control
and ‘peroxidized’ mitochondria (mitochondria exposed to
Fe2 plus ascorbate) were labeled with the protein-speci¢c
MAL-6 and their spectra were recorded by ESR spectroscopy.
Exposure of mitochondria to oxidative stress markedly re-
duced the W/S ratio within a short-term incubation of only
15 min (see Fig. 3A). On the contrary, when £upirtine was
present no marked decline in the W/S ratio was seen. How-
ever, when RLM were exposed to longer periods of oxidative
stress the W/S ratio ¢nally declined also (see Fig. 3B). Mem-
brane proteins are protected against oxidative stress by £upir-
tine with less e⁄ciency. Thus, the W/S ratio disappeared after
a 45-min exposure of mitochondria to Fe2 plus ascorbate,
whereas the formation of TBARS was completely suppressed
after more than a 2-h exposure of mitochondria.
3.3. Respiratory control and Ca2+ retention capacity
The respiratory control ratio (RCR) rapidly decreased dur-
ing treatment of RLM with Fe2 plus ascorbate (see Fig. 4A),
mainly due to an inhibition of the ADP-linked respiration
(state 3). Only a 15-min exposure of RLM to oxidative stress
was su⁄cient to half the RCR. After 45 min of oxidative
stress, RLM lost their respiratory control completely. How-
ever, in the presence of £upirtine (20 WM) the decline in RCR
was signi¢cantly delayed. Similar to RCR, oxidative stress
reduced the Ca2 retention capacity of mitochondria. The
ability of ‘peroxidized’ RLM to accumulate Ca2 from the
medium is remarkably reduced after 15 min of Fe2 plus
ascorbate treatment. After a further 15 min of oxidative
stress, mitochondria were not further able to accumulate
added Ca2 (see Fig. 4B). Flupirtine (20 WM) preserved the
ability of RLM to accumulate Ca2 from medium under
short-term oxidative stress for more than 30 min. Generally,
a high Ca2 retention capacity indicates that mitochondria are
quali¢ed to bu¡er external Ca2 at a low level. Exhausting the
Fig. 2. E¡ect of £upirtine on the formation of the DMPO/OH ad-
duct. Hydroxyl radicals were generated by rapid mixing of 50 nmol
Fe2 with 32 Wmol H2O2 in 1 ml PBS medium supplemented with
1 mM DMPO. ESR spectra of the DMPO/OH adduct were ob-
tained in the absence (A) or in the presence of £upirtine (100 WM;
B). The dependence of the formation of DMPO/OH adduct
(100 WM DMPO) on the concentration of £upirtine is shown in (C).
The results shown are the mean of four separate experiments.
Fig. 3. E¡ect of £upirtine on the physical state of membrane pro-
teins exposed to Fe2/ascorbate-generated oxidative stress. RLM
were treated with Fe2/ascorbate as in Fig. 1 in the absence or pres-
ence of £upirtine (20 WM). At various incubation intervals aliquots
of the reaction mixture were centrifuged. After aspiration of the
supernatant, the pellet was washed with incubation medium (with-
out Fe2, ascorbate, £upirtine). Finally, the resuspended pellet was
labeled with MAL-6 as described in Section 2. A: Typical low-¢eld
ESR spectra of bound MAL-6 to control RLM and those peroxi-
dized in the absence or in the presence of £upirtine (20 WM) are
shown. B: Time course of W/S ratio during treatment of RLM with
Fe2/ascorbate in the presence or absence of £upirtine (20 WM). The
data shown are the mean of two independent experiments.
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Ca2 bu¡er capacity is long known to trigger PT in function-
ally intact mitochondria (see [11] for review).
3.4. ANT activity
The ANT is a core protein of the so-called PT complex and
contains oxidizable -SH groups, which are functionally essen-
tial for its activity [11,24^28]. Therefore, we studied the ability
of £upirtine to preserve the ANT activity to exchange adenine
nucleotides across the inner mitochondrial membrane. Treat-
ment of RLM with Fe2 plus ascorbate initiated a linear
reduction in the ANT activity within 1 h (see Fig. 5). The
observed decrease in [14C]ADP uptake resulted from a decline
in the speci¢c ANT-based ADP uptake and, an increase in the
apparent unspeci¢c binding of [14C]ADP to the pellet. When
the incubation medium was supplemented with £upirtine (20
WM), the speci¢c exchange activity was preserved to a remark-
able degree for about 1 h.
4. Discussion
The results presented in this study indicate that low con-
centrations of the triaminopyridine derivative £upirtine pro-
tect remarkably the functional integrity of RLM exposed to
strong oxidative stress. This is evidenced by preservation of
the respiratory control (Fig. 4A), the Ca2 retention capacity
(Fig. 4B) or the activity of the ANT (Fig. 5). Especially, the
ANT seems to be well protected by £upirtine against the
attacks of ROS. Thus, even after 60 min of exposure of
RLM to strong oxidative stress, £upirtine preserved the activ-
ity of ANT to about 50% of the control.
These observations are in line with the ability of £upirtine
to inhibit powerfully the peroxidation mitochondrial mem-
brane lipids (Fig. 1) and, with less e⁄ciency, the oxidation
of membrane proteins (see also [13]). The protection of mem-
brane proteins against oxidative stress is clearly seen in the
change in the W/S ratio in RLM exposed to oxidative stress in
the absence or presence of £upirtine (Fig. 3). The oxidant-
induced decrease in the W/S ratio has been attributed to an
aggregation of membrane proteins, a change in protein con-
formation and a decrease in the amount of accessible -SH
groups (see [29] for discussion).
Moreover, our results indicate further, that £upirtine prob-
ably acts as a free radical scavenger. A direct capture of ROS
by £upirtine is supported by its ability to diminish the amount
of the DMPO-OH adduct (Fig. 2), formed when the spin trap
DMPO reacts with hydroxyl radicals (generated from Fe2
plus H2O2). The complexation of iron ions by £upirtine as a
cause of its antioxidative e¡ect is not very likely, since, con-
trary to a variety of unsaturated organic compounds applied
in colorimetric iron assays, we did not found that mixing of
£upirtine with increasing concentrations of Fe2 or Fe3
changed its spectral properties (not shown). Furthermore, £u-
pirtine protects membrane lipids against ROS attacks similar
to the lipid-soluble K-tocopherol (or even more e¡ective),
while the water-soluble antioxidant DMPO was ine¡ective.
We therefore propose that £upirtine captures ROS near the
membrane, in addition to its ability to capture ROS in the
bulk phase. This idea is supported by the observation that an
incubation of mitochondria with increasing concentrations of
£upirtine (0^50 WM) increased slightly the W/S ratio (124 þ 5%
of control, three experiments), indicating that £upirtine inter-
acts with the membrane components. However, we got no
hint of an enrichment of £upirtine inside the mitochondria.
A possible membrane potential-driven accumulation of the
cationic £upirtine was excluded from the observation, as an
addition of succinate to a mixture of antimycin A-treated
RLM plus £upirtine did not change its £uorescence intensity
(not shown).
Preservation of the Ca2 bu¡er capacity and of the ANT
activity makes £upirtine interesting as a tool to prevent oxi-
Fig. 4. Preservation of respiratory control and Ca2 retention ca-
pacity. Isolation of RLM from the peroxidation mixture was carried
out as in Fig. 3. A: Respiratory control was measured as in Section
2 (¢ve separate experiments). B: Ca2 retention capacity was esti-
mated as in Section 2 (six separate experiments). The Ca2 retention
capacity in ‘control’ mitochondria was 115 þ 16 nmol Ca2/mg pro-
tein (100%). Control incubations of RLM were done in KCl^Tris
medium in the absence of Fe2 plus ascorbate or £upirtine.
Fig. 5. E¡ect of £upirtine on the ANT activity exposed to oxidative
stress. RLM were treated as in Fig. 3. The activity of ANT was
measured as described in Section 2 (six separate experiments). The
activity of ANT in ‘control’ mitochondria was 1.7 þ 0.3 nmol mg31
15 s31.
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dative stress-induced apoptosis. Generally, mitochondria have
been recently recognized to play a major role in the control of
the apoptotic death of mammalian cells (for recent reviews,
see [11,25^28]). Ca2 is a classical inducer of PT. Therefore, a
decreasing Ca2 retention capacity re£ects an increasing ten-
dency of mitochondria to undergo PT. In addition, ANT is a
central component of the so-called PT pore, a dynamic multi-
protein complex formed at the contact site between the inner
and the outer mitochondrial membranes [11,24^27]. It has
been reported that the ANT has -SH groups that are suscep-
tible to oxidative stress and that their oxidative modi¢cation
reduces severely the e¡ectiveness of ADP as an inhibitor of
PT [11,28]. The protection of mitochondria against PT might
partly explain how £upirtine counteracted apoptosis in cell
cultures at oxidative stress [14,15].
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